OXY-2-15, a novel variant showing increased ceftazidime hydrolytic activity

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 5, 2014, Pages 1429-1433

  Nijhuis, R H T ^a   Oueslati, S ^b   Zhou, K ^c   Bosboom, R W ^a   Rossen, J W A ^c   Naas, T ^b  

^a Laboratory for Medical Microbiology and Immunology   (Netherlands)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Antimicrobial resistance mechanisms; Bla genes; Enterobacteriaceae; ESBLs; Gram negative; K1; KOXY

Indexed keywords

AMOXICILLIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE OXY 2 15; BETA LACTAMASE OXY 2 2; BETA LACTAMASE OXY 2 5; CEFALORIDINE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; IMIPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN; TEMOCILLIN; TICARCILLIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE REPORT; CATALYTIC EFFICIENCY; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HYDROLYSIS; IN VIVO STUDY; KLEBSIELLA OXYTOCA; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; SEPSIS; STEADY STATE; BACTERIAL GENOME; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; ENZYMOLOGY; GENETIC SELECTION; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFTAZIDIME; CLONING, MOLECULAR; DNA, BACTERIAL; GENOME, BACTERIAL; HUMANS; HYDROLYSIS; KLEBSIELLA INFECTIONS; KLEBSIELLA OXYTOCA; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SELECTION, GENETIC; SEPSIS; SEQUENCE ANALYSIS, DNA;

EID: 84929730349     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv002     Document Type: Article

References (18)

1. Fournier B, Lu CY, Lagrange PH et al. Point mutation in the pribnow box, the molecular basis of β-lactamase overproduction in Klebsiella oxytoca. Antimicrob Agents Chemother 1995; 39: 1365-8.
2. Fournier B, Gravel A, Hooper DC et al. Strength and regulation of the different promoters for chromosomal β-lactamases of Klebsiella oxytoca. Antimicrob Agents Chemother 1999; 43: 850-5.
3. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-33.
4. OXY-2. Antimicrob Agents Chemother 1996; 40: 454-9.
5. Fevre C, Jbel M, Passet Vet al. Six groups of the OXY β-lactamase evolved over millions of years in Klebsiella oxytoca. Antimicrob Agents Chemother 2005; 49: 3453-62.
6. Mammeri H, Poirel L, Nordmann P. In vivo selection of a chromosomally encoded β-lactamase variant conferring ceftazidime resistance in Klebsiella oxytoca. Antimicrob Agents Chemother 2003; 47: 3739-42.
7. Rodríguez-Martínez J-M, Poirel L, Nordmann P et al. Ceftazidime-resistant Klebsiella oxytoca producing an OXY-2-type variant from Switzerland. Int J Antimicrob Agents 2008; 32: 278-9.
8. Younes A, Hamouda A, Amyes SGB. First report of a novel extendedspectrum β-lactamase KOXY-2 producing Klebsiella oxytoca that hydrolyses cefotaxime and ceftazidime. J Chemother 2011; 23: 127-30.
9. Naas T, Aubert D, Özcan A et al. Chromosome-encoded narrowspectrum Ambler class A β-lactamase GIL-1 from Citrobacter gillenii. Antimicrob Agents Chemother 2007; 51: 1365-72.
10. Philippon LN, Naas T, Bouthors AT et al. OXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1997; 41: 2188-95.
11. Nederlandse Vereniging voor Medische Microbiologie (NVMM). Guideline: Laboratory Detection of Highly Resistant Microorganisms (HRMO). 2012. http://www.nvmm.nl/richtlijnen/hrmo-laboratory-detectionhighly-resistant-microorganisms.
12. Nijhuis R, van Zwet A, Stuart JC et al. Rapid molecular detection of extended-spectrum β-lactamase gene variants with a novel ligationmediated real-time PCR. J Med Microbiol 2012; 61: 1563-7.
13. Willemsen I, Hille L, Vrolijk A et al. Evaluation of a commercial real-time PCR for the detection of extended spectrum β-lactamase genes. J Med Microbiol 2014; 63: 540-3.
14. Zankari E, Hasman H, Cosentino S et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 2012; 67: 2640-4.
15. Ambler RP, Coulson AF, Frere JM et al. A standard numbering scheme for the class A β-lactamases. Biochem J 1991; 276: 269-70.
16. Poirel L, Naas T, Le Thomas I et al. CTX-M-type extended-spectrum β-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother 2001; 45: 3355-61.
17. Djamdjian L, Naas T, Tande D et al. CTX-M-93, a CTX-M variant lacking penicillin hydrolytic activity. Antimicrob Agents Chemother 2011; 55: 1861-6.
18. Vakulenko S, Golemi D. Mutant TEM β-lactamase producing resistance to ceftazidime, ampicillins, and β-lactamase inhibitors. Antimicrob Agents Chemother 2002; 46: 646-53.